Published on:
    Journal of Cardiovascular Disease Research, 2012; 3(4):255-264
    REVIEW ARTICLE | doi:10.4103/0975-3583.102690

    Trends in the management of atrial fibrillation: A neurologist’s perspective


    Vishnumurthy Shushrutha Hedna, Christopher G Favilla, Waldo R Guerrero, Akhil Patel, Amareshwari Gottipati, Sharathchandra Bidari1, Thomas Beaver2, Michael F Waters

    Departments of Vascular Neurology, 1Neuro-Radiology,

    2Cardiothoracic Surgery, University of Florida, Gainesville , USA.


    Cardiac embolism, primarily from atrial fibrillation (AF), is implicated in a quarter of all ischemic strokes. In the setting of AF, contraindications to traditional therapies can create a clinical dilemma when choosing an agent for secondary stroke prophylaxis. Newer horizons in the medical and surgical management of AF have helped us choose from a wide variety of available therapies, the best possible management. In this article, we review the current trends in AF management including newer oral anticoagulants as well as surgical devices from a neurologist’s view.

    Key words: Anticoagulation, atrial fibrillation, atriclip, reversal of anticoagulation.